Skip to content

Clinical trials

Kidney Diseases trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Diseases Country / region: Norway Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20102
20111
20152
20161
20181
20191
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Helse Nord-Trøndelag HF2
AstraZeneca1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Haukeland University Hospital1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Oslo University Hospital1
Prof Stig Larsen1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Diseases11
Liver Diseases3
Aortic Diseases2
Diabetes Mellitus, Type 22
Diabetic Nephropathies2
Dyspnea2
Heart Diseases2
Heart Failure2
Anemia1
Diabetes Mellitus1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.